Evaluating the President's Emergency Plan for AIDS Relief: Time to scale it up

Annals of Internal Medicine

Volumn 150, Issue 10, 2009, Pages

  Gross, Robert ^a   Bisson, Gregory P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANTIVIRAL THERAPY; EDITORIAL; GOVERNMENT; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MORTALITY; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION; AFRICA SOUTH OF THE SAHARA; EPIDEMIC; HEALTH CARE QUALITY; HEALTH PROMOTION; INTERNATIONAL COOPERATION; LEGAL ASPECT; NOTE; OUTCOME ASSESSMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; DISEASE OUTBREAKS; FEDERAL GOVERNMENT; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION;

EID: 66149163211     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-10-200905190-00012     Document Type: Editorial

References (10)

1. U.S. Department of State. Engendering Bold Leadership: First Annual Report to Congress on PEPFAR. Washington, DC; U.S. Government, Office of the U.S. Global AIDS Coordinator; 2005. Accessed at www.state.gov/s/gac/rl/c14961. htm on 15 April 2009.
2. Bendavid E, Bhattacharya J. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes. Ann Intern Med. 2009;150:688-695
3. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337:725-733 [PMID: 9287227]
4. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al; Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824 [PMID: 16530575]
5. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180 [PMID: 7935654]
6. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929 [PMID: 10738050]
7. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48 [PMID: 9660362]
8. U.S. Department of State. Celebrating Life: The US President's Emergency Plan for AIDS Relief 2009 Annual Report to Congress. Washington, DC; U.S. Government, Office of the U.S. Global AIDS Coordinator; 2009. Accessed at www.pepfar.gov/press/fifth-annual-report on 15 April 2009.
9. Framework for program evaluation in public health. MMWR Recomm Rep. 1999;48:1-40. [PMID: 10499397]
10. Sepulveda J, Carpenter C, Curran J, Holzemer W, Smits H, Scott K, et al, eds. PEPFAR Implementation: Progress and Promise. Washington, DC: National Academies Pr; 2007.